Table 2.
First author [Ref.], year | Representative of sarcopenia patients | Selection of control | Ascertain of sarcopenia measurement | Outcome of interest not present at start | Comparability of cohorts | Assessment of outcome | Enough follow-up period | Adequacy of follow-up | Total points |
---|---|---|---|---|---|---|---|---|---|
Dodson [31], 2013 | * | * | * | * | ** | * | * | * | 9 |
Harimoto [21], 2013 | * | * | * | * | * | * | * | * | 8 |
Meza-Junco [29], 2013 | * | * | * | * | ** | * | - | * | 8 |
Itoh [22], 2014 | * | * | * | * | ** | * | * | * | 9 |
Fujiwara [20], 2015 | * | * | * | * | ** | * | * | * | 9 |
Iritani [28], 2015 | * | * | * | * | ** | * | * | * | 9 |
Levolger [24], 2015 | * | * | * | * | ** | * | * | * | 9 |
Valero [30], 2015 | * | * | * | * | ** | * | * | * | 9 |
Voron [26], 2015 | * | * | * | * | ** | * | * | * | 9 |
Kamachi [23], 2016 | * | * | * | * | * | * | * | * | 8 |
Takagi [25], 2016 | * | * | * | * | ** | * | * | * | 9 |
Yabusaki [27], 2016 | * | * | * | * | ** | * | - | - | 7 |
Hiraoka [32], 2017 | * | * | * | * | ** | * | * | * | 9 |